Biotecnología
Biotecnología
MaaT Pharma, Skyepharma Finish Microbiome Ecosystem Therapies Facility
18/09/2023 -
Facility designed to support MaaT Pharma’s clinical-and commercial-scale manufacturing of Microbiome Ecosystem Therapies.
Sartorius, Repligen Partner on Integrated Bioreactor System
18/08/2023 -
Bioreactor and cell technology features a single direct control interface to simplify intensified seed train implementation.
Sartorius, Emerson Partner to Integrate Bioreactors with DCS Technology
07/08/2023 -
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations.
GARDP, Bugworks Partner to Accelerate Novel Antibiotic
31/07/2023 -
New broad-spectrum antibiotic compound aims to treat serious infections caused by multidrug-resistant bacteria.
Agilent Invests $22M in Newport, DE Manufacturing Facility
11/07/2023 -
Produces liquid chromatography columns for chemical and biochemical analysis, drug discovery, environmental control, and analytical chemistry.
SK bioscience COVID-19 Vaccine Granted Emergency Use by WHO
23/06/2023 -
SKYCovione induced neutralizing antibody responses against SARS-CoV-2 parental strain and had a standard safety and reactogenicity profile.
Cytiva Bioreactor Features Mass Flow Controllers from Brooks Instrument
15/06/2023 -
SLA Series Biotech MFC offers intelligent, precise gas flow control designed to reduce complexity and costs in bioprocessing operations.
Resilience, 908 Devices Demonstrate Lower Cost of Perfusion Bioreactor Process
05/05/2023 -
Adopts REBEL at-line media analyzers in process development to inform and optimize cell culture feed strategies and media design.
Charles River Launches Accugenix NGS for Bacterial and Fungal Identification
05/05/2023 -
Sequences millions of individual DNA fragments from a sample and offers a snapshot of the microbiome, providing key information about microbial control.
Bacthera Joins Microbiome Therapeutics Innovation Group
25/04/2023 -
Alliance expected to accelerate microbiome therapeutic product development and manufacturing.
CCRM Partners with Membio to Streamline Production of Viral Vectors for Cell and Gene Therapies
10/01/2023 -
Will explore combining Membio’s bioreactor system with CCRM’s virus producing cell line.
Viralgen Expands Capacity with cGMP Certification
10/01/2023 -
New facility in Spain operates single-use bioreactors from 50 to 2,000 liters and manufactures research, clinical and commercial grade rAAV vectors.
The AMR Action Fund Invests in BioVersys in Fight Against Drug-Resistant Bacteria
09/01/2023 -
Deal aims to advance its mission of enabling the launch of two to four antimicrobials by 2030.
Applied Cells Inc. and GenScript USA Enter Strategic Collaboration
23/11/2022 -
Will deliver combined cell isolation solutions for cell therapy drug development worldwide.
WuXi Vaccines Establishes New Vaccines CDMO Facility in China
16/11/2022 -
The 8,500-square-meter facility includes multiple 250L, 500L and 1000L single-use bioreactors as well as sterile drug-product manufacturing lines.
Gut Microbiome Therapy to be Approved in the Next Two Years
10/11/2022 -
The promise of microbiome-based therapeutics is rapidly progressing towards real world applications.
Alcohol Use Can Alter Gut Microbes, but Not in the Way You Might Think
12/08/2022 -
In mouse studies, UC San Diego researchers find that excess alcohol consumption alters gut microbiome but latter is not directly or significantly linked to liver disease.
Engineering the Microbiome to Potentially Cure Disease
05/08/2022 -
UC San Diego researchers report using native bacteria in mice as the chassis for delivering transgenes capable of inducing persistent and potentially even curative therapeutic changes in the gut and...
Giant Viruses Build a Cell Nucleus Surprisingly Like Our Own
04/08/2022 -
Scientists are using new technologies to obtain unprecedented looks inside viruses and their unique abilities to infect and destroy bacteria. Using cryo-EM and other technologies, they found that...
Univercells Technologies Partners with TFBS Bioscience
20/07/2022 -
TFBS will leverage scale-X carbo mid-scale fixed-bed bioreactor from Univercells for GMP viral vector operations at the CDMO’s New Taipei City facility.
Familiarity Breeds Exempt: Why Staph Vaccines Don’t Work in Humans
09/07/2022 -
UC San Diego researchers say they may have found the reason why multiple human clinical trials of staphylococcus vaccines have failed: the bacteria knows us too well.
